Results 141 to 150 of about 3,893,535 (160)

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up. [PDF]

J Nucl Med
Severi S, Grassi I, Bongiovanni A, Nicolini S, Marini I, Arpa D, Ranallo N, Azzali I, Di Iorio V, Sarnelli A, Manuela M, Amadori E, Fabbri L, Bartolini D, Tosatto L, Di Meco F, Gurrieri L, Riva N, Calabro L, Matteucci F, Paganelli G, Sansovini M.   +21 more
europepmc   +1 more source

Efficacy and Safety of Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis of Comparative Studies.

Cureus
Zhao J, Pei X, Li Y.
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy [PDF]

Journal of Clinical Endocrinology and Metabolism, 2022
The concept of using a targeting molecule labeled with a diagnostic radionuclide for using positron emission tomography or single photon emission computed tomography imaging with the potential to demonstrate that tumoricidal radiation can be delivered to
Tessa Brabander, Johannes Hofland, Frederik Verburg   +2 more
exaly   +3 more sources

Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements

Cancers, 2023
Neuroendocrine neoplasms (NENs) are tumors originating from neuroendocrine cells distributed throughout the human body. With an increasing incidence over the past few decades, they represent a highly heterogeneous group of neoplasms, mostly expressing ...
Elettra Merola, Chiara Maria Grana
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Peptide receptor radionuclide therapy in neuroendocrine neoplasms and related tumors: from fundamentals to personalization and the newer experimental approaches

Expert Review of Precision Medicine and Drug Development, 2023
Sandip Basu
exaly  

Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies

Cancers, 2022
Jeroen Dekervel, Paul Clement, Christophe Deroose   +2 more
exaly  

Clinical efficacy of first and second series of peptide receptor radionuclide therapy in patients with neuroendocrine neoplasm: a cohort study

Scandinavian Journal of Gastroenterology, 2021
Henning Grønbæk, Simon Mark Dahl Jørgensen   +1 more
exaly  

A Clinical Guide to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients

Cancers, 2022
Tessa Brabander, Julie Nonnekens, Johannes Hofland   +2 more
exaly  

Treatment of neuroendocrine tumours with 177Lu-peptide receptor radionuclide therapy: Challenging clinical scenarios and their management

Journal of Neuroendocrinology, 2022
Christos Toumpanakis, Gopinath Gnanasegaran, Martyn Caplin   +2 more
exaly  

Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward

Current Topics in Medicinal Chemistry, 2020
Julie Nonnekens, Marion de Jong
exaly